These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8352253)

  • 21. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J; Casaretto A; Albers J
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns.
    Franceschini G; Sirtori CR; Bosisio E; Gualandri V; Orsini GB; Mogavero AM; Capurso A
    Atherosclerosis; 1985 Dec; 58(1-3):159-74. PubMed ID: 3937534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further definition of lipid-lipoprotein abnormalities in children with various degrees of chronic renal insufficiency.
    Zacchello G; Pagnan A; Sidran MP; Ziron L; Braggion M; Pavanello L; Facchin P
    Pediatr Res; 1987 May; 21(5):462-5. PubMed ID: 3588083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients.
    Docci D; Capponcini C; Mengozzi S; Baldrati L; Neri L; Feletti C
    Nephron; 1995; 69(3):323-6. PubMed ID: 7753268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Vanichakarn S; Nimmannit S; Chirawong P; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract]   [Full Text] [Related]  

  • 28. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
    Abate N; Vega GL; Garg A; Grundy SM
    Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
    Ginsberg HN
    Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance.
    Yanagi K; Yamashita S; Kihara S; Nakamura T; Nozaki S; Nagai Y; Funahashi T; Kameda-Takemura K; Ueyama Y; Jiao S; Kubo M; Tokunaga K; Matsuzawa Y
    Atherosclerosis; 1997 Jul; 132(1):43-51. PubMed ID: 9247358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
    Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
    Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia.
    Tschöpe W; Koch M; Thomas B; Ritz E
    Nephron; 1993; 64(3):354-8. PubMed ID: 8341379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.
    Rantapää-Dahlqvist S; Wållberg-Jonsson S; Dahlén G
    Ann Rheum Dis; 1991 Jun; 50(6):366-8. PubMed ID: 1829348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis.
    Oda H; Yorioka N; Okushin S; Nishida Y; Kushihata S; Ito T; Yamakido M
    Nephron; 1997; 76(1):7-14. PubMed ID: 9171293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.